Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.06
Tweet Send to a FriendGet Alerts HBIO Hot Sheet
Price: $5.10 -1.54%
Revenue Growth %: -7.8%
Financial Fact:
Operating income: -158K
Today's EPS Names:
MGT, RXN, KID, More
Revenue Growth %: -7.8%
Financial Fact:
Operating income: -158K
Today's EPS Names:
MGT, RXN, KID, More
Trade HBIO Now!
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.06, versus $0.08 reported last year. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.1 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- TJX Cos. (TJX) Reports In-Line Q1 EPS; Guides Q2 EPS, Narrows FY14 Outlook
- Kid Brands (KID) Posts Surprise Q1 Profit
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
